Skip to main content
. 2018 May 11;7(5):39. doi: 10.1038/s41389-018-0048-4

Fig. 2. CARF enrichment correlates with metastatic progression in clinical tumors.

Fig. 2

a Immunohistochemical staining showing CARF expression in normal, infiltrating, and metastatic breast cancer patient tumors; their quantitative levels shown on right. b, CARF levels in patients with normal to infiltrating (sub-group #1) and infiltrating to metastatic (sub-group #2) breast tumors in different age groups; quantitation shown below. c Expression of CARF in normal and metastatic tumor sections of intestine, liver and skin; quantitation shown on right. d Quantitation of CARF expression in normal and malignant breast, prostate, skin, liver, and kidney tumors sections; and in normal, lobular, and ductal breast cancer immunohistological sections retrieved from Human Protein Atlas (e)